Myasthenia gravis associated with etanercept therapy

Dominic B. Fee, Edward J. Kasarskis

Research output: Contribution to journalArticlepeer-review

52 Scopus citations


Etanercept is an antagonist of tumor necrosis factor alpha that was developed to treat rheumatoid arthritis. In this report we present a patient who developed myasthenia gravis while taking etanercept and had resolution of symptoms after stopping it. This is the first report of this potential side effect and is of additional interest, because etanercept has been proposed as a treatment for myasthenia gravis.

Original languageEnglish
Pages (from-to)866-870
Number of pages5
JournalMuscle and Nerve
Issue number6
StatePublished - Jun 2009


  • Acetylcholine receptor antibodies
  • Enbrel
  • Etanercept
  • Myasthenia gravis
  • Pathophysiology

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)


Dive into the research topics of 'Myasthenia gravis associated with etanercept therapy'. Together they form a unique fingerprint.

Cite this